icon-folder.gif   Conference Reports for NaTaP  
 
  EASL - The International Liver Congress 2015
50th annual Meeting of the European
association for the Study of the Liver
Vienna, austria  april 22-26
Back grey_arrow_rt.gif
 
 
 
Efficacy of the oral Sofosbuvir-based combination in HCV genotype 4-monoinfected patients from the French observational cohort ANRS CO22 HEPATHER
 
 
  Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
 
Helene FONTAINE1, Christophe HEZODE2, Fabien ZOULIM3, Didier SAMUEL4, Marc BOURLIERE5, Georges HAOUR6, Celine DORIVAL6, Vincent LEROY7, Victor DE LEDINGHEN8, Sandy LUCIER6 , Dominique LARREY9, Albert TRAN10, Sophie METIVIER11, Yves BENHAMOU12, Isabelle HUBERT-FOUCHARD13, François HABERSETZER14, Patrick MARCELLIN15, Philippe MATHURIN16, Laurent ALRIC17, Jean-Pierre BRONOWICKI18, Dominique GUYADER19, Veronique LOUSTAUD-RATTI20, Anne MINELLO21, Ghassan RIACHI22, Isabelle ROSA23, Melanie SIMONY24, Alpha DIALLO25, Fabrice CARRAT6,26, Stanislas POL1 and the ANRS/AFEF HEPATHER Study group.
 
1 Department of Hepatology, Hopital Cochin, APHP, Universite Paris Descartes, Inserm UMS20, Institut Pasteur, Paris, France; 2 Department of Hepatology and Gastroenterology, Hopital Henri Mondor, AP-HP, Universite Paris-Est, INSERM U955, Creteil, France; 3 Department of Hepatology, Hospices Civils de Lyon, INSERM U1052, Universite de Lyon, Lyon, France; 4 Centre Hepato-Biliaire, Hopital Paul Brousse, AP-HP, UMR-S785, Universite Paris-Sud, INSERM U785, Villejuif, France; 5 Department of Hepatology and Gastroenterology, Hopital Saint Joseph, Marseille, France; 6 INSERM UMR-S 1136, Universite Pierre et Marie Curie Paris 6, Paris, France; 7 Department of Hepatology and Gastroenterology, Centre Hospitalo-Universitaire, INSERM U823, Grenoble, France; 8 Hepatology Unit, CHU Bordeaux, INSERM U1053, Universite Bordeaux, Bordeaux, France ; 9 Liver unit-IRB-INSERM1040, Hopital Saint Eloi, Montpellier, France; 10 Digestive Center, Centre Hospitalier Universitaire de Nice, INSERM U1065-8, Nice, France; 11 Department of Hepatology and Gastroenterology, CHU Purpan, Toulouse, France; 12 Department of Hepatology and Gastroenterology, Groupe Hospitalier Pitie-Salpetriere, AP-HP, Universite Pierre et Marie Curie Paris 6, INSERM UMR-S938, Paris, France; 13 Liver-Gastroenterology Department, CHU Angers, France; 14 CIC, Inserm 1110 et Hopitaux Universitaire de Strasbourg, France; 15 Department of Hepatology, Hopital Beaujon, AP-HP, Universite Paris-Diderot, INSERM CRB3, Clichy, France; 16 Department of Hepatology and Gastroenterology, Centre Hospitalier Regional et Universitaire Claude Huriez, Lille, France; 17 Department of Internal Medicine and Digestive Diseases, UMR-152, Toulouse III University, Toulouse, France; 18 Department of Hepatology and Gastroenterology, Centre Hospitalier Universitaire de Nancy, Universite de Lorraine, INSERM U954, Vandoeuvre-les-Nancy, France; 19 Liver disease unit, CHU Rennes, Universite de Rennes 1, INSERM U991, Rennes, France; 20 Department of Hepatology and Gastroenterology, CHU Dupuytren, Universite de Limoges, UMR INSERM U1092, Limoges, France; 21 Department of Hepatology and Gastroenterology, CHU de Dijon, Universite de Bourgogne, Dijon, France; 22 Department of Hepatology and Gastroenterology, CHU Charles Nicolle, Rouen, France; 23 Department of Hepatology and Gastroenterology, Centre Hospitalier Intercommunal, Creteil, France; 24 Unit for Basic and Clinical research on viral hepatitis, French National Agency for research on Aids and viral Hepatitis, Paris, France; 25 Clinical Research Safety Office, ANRS, Paris; 26 Public Health Department, APHP, Paris.

EASL1.gif

Helene FONTAINE1, Christophe HEZODE2, Fabien ZOULIM3, Didier SAMUEL4, Marc BOURLIERE5, Georges HAOUR6, Celine DORIVAL6, Vincent LEROY7, Victor DE LEDINGHEN8, Sandy LUCIER6 , Dominique LARREY9, Albert TRAN10, Sophie METIVIER11, Yves BENHAMOU12, Isabelle HUBERT-FOUCHARD13, François HABERSETZER14, Patrick MARCELLIN15, Philippe MATHURIN16, Laurent ALRIC17, Jean-Pierre BRONOWICKI18, Dominique GUYADER19, Veronique LOUSTAUD-RATTI20, Anne MINELLO21, Ghassan RIACHI22, Isabelle ROSA23, Melanie SIMONY24, Alpha DIALLO25, Fabrice CARRAT6,26, Stanislas POL1 and the ANRS/AFEF HEPATHER Study group.
 
1 Department of Hepatology, Hopital Cochin, APHP, Universite Paris Descartes, Inserm UMS20, Institut Pasteur, Paris, France; 2 Department of Hepatology and Gastroenterology, Hopital Henri Mondor, AP-HP, Universite Paris-Est, INSERM U955, Creteil, France; 3 Department of Hepatology, Hospices Civils de Lyon, INSERM U1052, Universite de Lyon, Lyon, France; 4 Centre Hepato-Biliaire, Hopital Paul Brousse, AP-HP, UMR-S785, Universite Paris-Sud, INSERM U785, Villejuif, France; 5 Department of Hepatology and Gastroenterology, Hopital Saint Joseph, Marseille, France; 6 INSERM UMR-S 1136, Universite Pierre et Marie Curie Paris 6, Paris, France; 7 Department of Hepatology and Gastroenterology, Centre Hospitalo-Universitaire, INSERM U823, Grenoble, France; 8 Hepatology Unit, CHU Bordeaux, INSERM U1053, Universite Bordeaux, Bordeaux, France ; 9 Liver unit-IRB-INSERM1040, Hopital Saint Eloi, Montpellier, France; 10 Digestive Center, Centre Hospitalier Universitaire de Nice, INSERM U1065-8, Nice, France; 11 Department of Hepatology and Gastroenterology, CHU Purpan, Toulouse, France; 12 Department of Hepatology and Gastroenterology, Groupe Hospitalier Pitie-Salpetriere, AP-HP, Universite Pierre et Marie Curie Paris 6, INSERM UMR-S938, Paris, France; 13 Liver-Gastroenterology Department, CHU Angers, France; 14 CIC, Inserm 1110 et Hopitaux Universitaire de Strasbourg, France; 15 Department of Hepatology, Hopital Beaujon, AP-HP, Universite Paris-Diderot, INSERM CRB3, Clichy, France; 16 Department of Hepatology and Gastroenterology, Centre Hospitalier Regional et Universitaire Claude Huriez, Lille, France; 17 Department of Internal Medicine and Digestive Diseases, UMR-152, Toulouse III University, Toulouse, France; 18 Department of Hepatology and Gastroenterology, Centre Hospitalier Universitaire de Nancy, Universite de Lorraine, INSERM U954, Vandoeuvre-les-Nancy, France; 19 Liver disease unit, CHU Rennes, Universite de Rennes 1, INSERM U991, Rennes, France; 20 Department of Hepatology and Gastroenterology, CHU Dupuytren, Universite de Limoges, UMR INSERM U1092, Limoges, France; 21 Department of Hepatology and Gastroenterology, CHU de Dijon, Universite de Bourgogne, Dijon, France; 22 Department of Hepatology and Gastroenterology, CHU Charles Nicolle, Rouen, France; 23 Department of Hepatology and Gastroenterology, Centre Hospitalier Intercommunal, Creteil, France; 24 Unit for Basic and Clinical research on viral hepatitis, French National Agency for research on Aids and viral Hepatitis, Paris, France; 25 Clinical Research Safety Office, ANRS, Paris; 26 Public Health Department, APHP, Paris.

EASL2.gif

EASL3.gif

EASL4.gif